Crucell, a Dutch biotech, says it is ready to run clinical trials on a new treatment for rabies that it developed with genetic technology, possibly leading to a replacement of current drugs. Crucell said its PER.C6 technology relies on human cells to produce drugs and it hopes to begin testing it on humans next year.

Full Story:

Related Summaries